Focal liver lesions: Can SonoVue-enhanced ultrasound be used to differentiate malignant from benign lesions?

Investigative Radiology

Volumn 42, Issue 8, 2007, Pages 596-603

  Dai, Ying ^a   Chen, Min Hua ^a   Yin, Shan Shan ^a   Yan, Kun ^a   Fan, Zhi Hui ^a   Wu, Wei ^a   Wang, Yan Bin ^a   Yang, Wei ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Contrast enhanced ultrasound; Focal liver lesion; Microbubble contrast agent; Ultrasound

Indexed keywords

SONOVUE;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; HEPATITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LIVER ADENOMA; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER HEMANGIOMA; LIVER INJURY; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; NONLINEAR SYSTEM; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 34447312478     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLI.0b013e318050ab29     Document Type: Article

References (27)

1. Tanaka S, Kitamura T, Fujita M, et al. Color Doppler flow imaging of liver tumors. AJR Am J Roentgenol. 1990;154:509-514.
2. Reinhold C, Hammers L, Taylor CR, et al. Characterization of focal hepatic lesions with duplex sonographic findings in 198 patients. AJR Am J Roentgenol. 1995;164:1131-1135.
3. Choi BI, Kim TK, Han JK, et al. Power versus conventional color Doppler sonography: comparison in the depiction of vasculature in liver tumors. Radiology. 1996;200:55-58.
4. Burns PN, Wilson SR, Simpson DH. Pulse inversion imaging of liver blood flow: improved method for characterizing focal masses with microbubble contrast. Invest Radiol. 2000;35:58-71.
5. Bertolotto M, Dalla Palma L, Quaia E, et al. Characterization of unifocal liver lesions with pulse inversion harmonic imaging after Levovist injection: preliminary results. Eur Radiol. 2000;10:1369-1376.
6. Kim TK, Choi BI, Han JK, et al. Hepatic tumors: contrast agent enhancement patterns with pulse-inversion harmonic US. Radiology. 2000;216:411-417.
7. Dill-Macky MJ, Burns PN, Khalili K, et al. Focal hepatic masses: enhancement patterns with SH U 508A and pulse-inversion US. Radiology. 2002;222:95-102.
8. Klibanov AL. Microbubble contrast agents: targeted ultrasound imaging and ultrasound-assisted drug-delivery applications. Invest Radiol. 2006;41:354-362.
9. Quaia E, Calliada F, Bertolotto M, et al. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology. 2004;232:420-430.
10. Ding H, Wang WP, Huang BJ, et al. Imaging of focal liver lesions: low-mechanical-index real-time ultrasonography with SonoVue. J Ultrasound Med. 2005;24:285-297.
11. Catalano O, Nunziata A, Lobianco R, et al. Real-time harmonic contrast material-specific US of focal liver lesions. Radiographics. 2005;25:333-349.
12. Huang-Wei C, Bleuzen A, Bourlier P, et al. Differential diagnosis of focal nodular hyperplasia with quantitative parametric analysis in contrast-enhanced sonography. Invest Radiol. 2006;41:363-368.
13. Albrecht T, Blomley M, Bolondi L, et al. EFSUMB Study Group guidelines for the use of contrast agents in ultrasound. Ultraschall Med. 2004;25:249-256.
14. Van Leeuwen MS, Noordzij J, Feldberg MAM, et al. Focal liver lesions: characterization with triphasic spiral CT. Radiology. 1996;201:327-336.
15. Nino-Murcia M, Olcott EW, Jeffrey RB Jr, et al. Focal liver lesions: pattern-based classification scheme for enhancement at arterial phase CT. Radiology. 2000;215:746-751.
16. Bryant TH, Blomley MJ, Albrecht T, et al. Improved characterization of liver lesions with liver-phase uptake of liver-specific microbubbles: prospective multicenter study. Radiology. 2004;232:799-809.
17. Nicolau C, Vilana R, Catala V, et al. Importance of evaluating all vascular phases on contrast-enhanced sonography in the differentiation of benign from malignant focal liver lesions. AJR Am J Roentgenol. 2006;186:158-167.
18. Leen E, Ceccotti P, Kalogeropoulou C, et al. Prospective multicenter trial evaluating a novel method of characterizing focal liver lesions using contrast-enhanced sonography. AJR Am J Roentgenol. 2006;186:1551-1559.
19. Nicolau C, Catala V, Vilana R, et al. Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation. Eur Radiol. 2004;14:1092-1099.
20. Hayashi M, Matsui O, Ueda K, et al. Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium. AJR Am J Roentgenol. 1999;172:969-976.
21. Hayashi M, Matsui O, Ueda K, et al. Progression to hypervascular hepatocellular carcinoma: correlation with intranodular blood supply evaluated with CT during intraarterial injection of contrast material. Radiology. 2002;225:143-149.
22. Isozaki T, Numata K, Kiba T, et al. Differential diagnosis of hepatic tumors by using contrast enhancement patterns at US. Radiology. 2003;229:798-805.
23. Furuse J, Nagase M, Ishii H, et al. Contrast enhancement patterns of hepatic tumours during the vascular phase using coded harmonic imaging and Levovist to differentiate hepatocellular carcinoma from other focal lesions. Br J Radiol. 2003;76:385-392.
24. Dietrich CF. Characterisation of focal liver lesions with contrast enhanced ultrasonography. Eur J Radiol. 2004;51(Suppl):S9-S17.
25. Xu HX, Lu MD, Liu GJ, et al. Imaging of peripheral cholangiocarcinoma with low-mechanical index contrast-enhanced sonography and SonoVue: initial experience. J Ultrasound Med. 2006;25:23-33.
26. Kim KW, Choi BI, Park SH, et al. Pyogenic hepatic abscesses: distinctive features from hypovascular hepatic malignancies on contrast-enhanced ultrasound with SH U 508A: early experience. Ultrasound Med Biol. 2004;30:725-733.
27. Youk JH, Kim CS, Lee JM. Contrast-enhanced agent detection imaging: value in the characterization of focal hepatic lesions. J Ultrasound Med. 2003;22:897-910.